2011 Annual Meeting | Assessment of Rapidly Progressive Dementias and Related Neurologic Conditions

Date Saturday 04/09/11

Time 04:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Allen J. Aksamit, Jr., MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnoses and work-up of common and uncommon conditions that may present as RPDs, including Creutzfeldt-Jakob disease and its many imitators.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
04:00 PM - 04:05 PM		Introduction Allen J. Aksamit, Jr., MD, FAAN
04:00 PM - 06:00 PM		Break
04:05 PM - 04:35 PM		Creutzfeldt-Jakob Disease and Related Disorders Michael D. Geschwind, MD, PhD, FAAN
04:35 PM - 04:40 PM		Questions and Answers Michael D. Geschwind, MD, PhD, FAAN
04:40 PM - 05:10 PM		Paraneoplastic and Autoimmune Disorders Steven Vernino, MD, PhD, FAAN
05:10 PM - 05:15 PM		Questions and Answers Steven Vernino, MD, PhD, FAAN
05:15 PM - 05:45 PM		Degenerative Disorders Bradley F. Boeve, MD, FAAN
05:45 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Allen J. Aksamit, Jr., MD, FAAN	Dr. Aksamit has nothing to disclose.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..

��ɫ��

��ɫ��